Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ocugen (OCGN) Equity Average (2016 - 2025)

Historic Equity Average for Ocugen (OCGN) over the last 11 years, with Q3 2025 value amounting to $3.3 million.

  • Ocugen's Equity Average fell 8855.92% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 million, marking a year-over-year decrease of 8855.92%. This contributed to the annual value of $35.1 million for FY2024, which is 3871.75% down from last year.
  • Per Ocugen's latest filing, its Equity Average stood at $3.3 million for Q3 2025, which was down 8855.92% from $9.5 million recorded in Q2 2025.
  • Over the past 5 years, Ocugen's Equity Average peaked at $116.0 million during Q2 2022, and registered a low of $3.3 million during Q3 2025.
  • For the 5-year period, Ocugen's Equity Average averaged around $59.0 million, with its median value being $54.5 million (2023).
  • Its Equity Average has fluctuated over the past 5 years, first soared by 66958.75% in 2021, then plummeted by 8855.92% in 2025.
  • Ocugen's Equity Average (Quarter) stood at $101.5 million in 2021, then fell by 21.32% to $79.8 million in 2022, then plummeted by 43.4% to $45.2 million in 2023, then decreased by 22.25% to $35.1 million in 2024, then plummeted by 90.63% to $3.3 million in 2025.
  • Its last three reported values are $3.3 million in Q3 2025, $9.5 million for Q2 2025, and $22.8 million during Q1 2025.